ID

36593

Descripción

Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient; ODM derived from: https://clinicaltrials.gov/show/NCT02069418

Link

https://clinicaltrials.gov/show/NCT02069418

Palabras clave

Versiones (1)
  1. 24/5/19 24/5/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

24 de mayo de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

Inglés

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
age over superior to 18
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
nsclc proved by a histological biopsy
Descripción

Non-Small Cell Lung Carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007131
egfr mutation status known with no activating egfr mutation
Descripción

EGFR gene mutation Status Known | EGFR Activating Mutation Absent

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3266992
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205309
UMLS CUI [2,1]
C2984891
UMLS CUI [2,2]
C0332197
indication of erlotinib therapy after at least one previous therapy
Descripción

Indication Erlotinib | Status post Prior Therapy Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C1135135
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1514463
UMLS CUI [2,3]
C1265611
patients who have signed an informed consent to participate in this study
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
life expectancy exceeding 12 weeks
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
who activity score between 0 and 2.
Descripción

WHO Physical activity score

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0043237
UMLS CUI [1,2]
C4482422
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindication for the initiation of erlotinib
Descripción

Medical contraindication Erlotinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1135135
refusal to sign the consent
Descripción

Informed Consent Refused

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1705116
progressive inflammatory disease
Descripción

Inflammatory disorder Progressive

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1290884
UMLS CUI [1,2]
C0205329
infection with the hiv virus
Descripción

HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
other malignant disease
Descripción

Malignant disease Other

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205394
life expectancy less than 12 weeks
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
major adults protected by french law
Descripción

Adult Protection Law France

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0001675
UMLS CUI [1,2]
C0412786
UMLS CUI [1,3]
C0220866
UMLS CUI [1,4]
C0016674
Volver a la parte superior de la página

Similar models

Eligibility Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent NCT02069418

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age over superior to 18
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma
Item
nsclc proved by a histological biopsy
boolean
C0007131 (UMLS CUI [1])
EGFR gene mutation Status Known | EGFR Activating Mutation Absent
Item
egfr mutation status known with no activating egfr mutation
boolean
C3266992 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205309 (UMLS CUI [1,3])
C2984891 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Indication Erlotinib | Status post Prior Therapy Quantity
Item
indication of erlotinib therapy after at least one previous therapy
boolean
C3146298 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Informed Consent
Item
patients who have signed an informed consent to participate in this study
boolean
C0021430 (UMLS CUI [1])
Life Expectancy
Item
life expectancy exceeding 12 weeks
boolean
C0023671 (UMLS CUI [1])
WHO Physical activity score
Item
who activity score between 0 and 2.
boolean
C0043237 (UMLS CUI [1,1])
C4482422 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Medical contraindication Erlotinib
Item
contraindication for the initiation of erlotinib
boolean
C1301624 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
Informed Consent Refused
Item
refusal to sign the consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Inflammatory disorder Progressive
Item
progressive inflammatory disease
boolean
C1290884 (UMLS CUI [1,1])
C0205329 (UMLS CUI [1,2])
HIV Infection
Item
infection with the hiv virus
boolean
C0019693 (UMLS CUI [1])
Malignant disease Other
Item
other malignant disease
boolean
C0442867 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy less than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Adult Protection Law France
Item
major adults protected by french law
boolean
C0001675 (UMLS CUI [1,1])
C0412786 (UMLS CUI [1,2])
C0220866 (UMLS CUI [1,3])
C0016674 (UMLS CUI [1,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial